Soluble CXCL-13 and galectin-9 had very good specificity and sensitivity in detecting CLL disease progression and high-risk patients with the superiority of galectin-9 over CXCL-13. The gene discussed is LGALS9; the disease is B-cell chronic lymphocytic leukemia.